Intranasal combo: fixed-dose combination of mometasone furoate and olopatadine hydrochloride in therapeutic strategies for rhinosinusitis-Reference-Cited by-同舟云学术

Intranasal combo: fixed-dose combination of mometasone furoate and olopatadine hydrochloride in therapeutic strategies for rhinosinusitis

Published:2023-12-04 Issue:6 Volume:77 Page:43-50
ISSN:0030-6657
Container-title:Otolaryngologia Polska
language:
Short-container-title:Otolaryngol Pol

Author:

Samoliński Bolesław¹^ORCID,Wojas Oksana¹^ORCID,Lipiec Agnieszka¹^ORCID,Krzych-Fałta Edyta²^ORCID,Walkiewicz Artur¹,Borowicz Jacek¹^ORCID,Samoliński Krzysztof³

Affiliation:

1. Department of the Prevention of Environmental Hazards, Allergology and Immunology, Medical University of Warsaw, Poland

2. Department of Basic Nursing, Medical University of Warsaw

3. Department of Emergency Medicine, Medical University of Warsaw

Abstract

A novel strategy for the treatment of allergic rhinitis results from the innovative combination of antihistamine and intranasal corticosteroid drugs. By combining two preparations with different mechanism of action, this novel approach facilitates quick and effective controls of all upper respiratory tract allergy symptoms. The article presents the results of a study of olopatadine hydrochloride and mometasone furoate fixed-dose combination (GSP301) administered intranasally from a spray formulation, with an attempt at positioning the treatment within the ARIA and EPOS guidelines.

Publisher

Index Copernicus

Subject

Otorhinolaryngology

Link

https://otolaryngologypl.com/gicid/pdf/01.3001.0054.0941

Reference48 articles.

1. Samoliński B., Raciborski F., Lipiec A. et al.: Epidemiologia chorób w Polsce(ECAP). Polish Journal of Allergology, 2014; 1: 10–18.

2. Samoliński B., Raciborski F., Krzych-Fałta E.: RAPORT KOŃCOWY projektuNPZ na lata 2016-2020 Ministerstwo Zdrowia, pt.: Badanie, rozwijanie i promowanie zagadnień związanych z czynnikami ryzyka chorób alergicznych i astmy,w tym szczególnie pochodzenia powietrzno-pochodnego. Warszawa 2018.

3. Bousquet J., Khalataev N., Alvaro A. et al.: Allergic Rhinitis and its Impact onAsthma (ARIA) 2008. Alergia Astma Immunologia Kliniczna, 2008; 13(1): 3–39.

4. Brozek J.L., Bousquet J., Baena-Cagnani C.E. et al.: Allergic Rhinitis and itsImpact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol.,2010; 126(3): 466–476.

5. Bousquet J., Van Cauwenberge P., Khaltaev N., Aria Workshop Group, WorldHealth Organization: Allergic rhinitis and its impact on asthma. J Allergy ClinImmunol., 2001; 108(5 Suppl): S147–S334.